Hanover Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$418K Hold
5,580
– – 0.15% 80
2026
Q2
$441K Hold
5,580
– – 0.16% 77
2026
Q1
$481K Hold
5,580
– – 0.2% 68
2025
Q4
$487K Hold
5,580
– – 0.19% 63
2025
Q3
$320K Hold
5,580
– – 0.12% 80
2025
Q2
$329K Hold
5,580
– – 0.13% 69
2025
Q1
$408K Hold
5,580
– – 0.18% 58
2024
Q4
$462K Hold
5,580
– – 0.19% 51
2024
Q3
$399K Hold
5,580
– – 0.17% 59
2024
Q2
$382K Hold
5,580
– – 0.17% 60
2024
Q1
$299K Hold
5,580
– – 0.13% 77
2023
Q4
$297K Buy
+5,580
New +$272K 0.15% 72

Other funds holding GMED

Hanover Advisors's GMED Position: Q3 2026 in Review

Hanover Advisors held its Globus Medical (GMED) position steady in Q3 2026 at 5,580 shares worth $418K. The position accounts for 0.15% of the portfolio, ranked #80.

Hanover Advisors first reported a position in GMED in Q4 2023 and has held it in 12 quarters since. The position peaked at $487K in Q4 2025. 615 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

  • Hanover Advisors held 5,580 shares of Globus Medical worth $418K as of Q3 2026.
  • Hanover Advisors left its Globus Medical share count unchanged in Q3 2026.
  • Globus Medical made up 0.15% of Hanover Advisors's portfolio in Q3 2026, its #80 holding.
  • Hanover Advisors first reported a position in Globus Medical in Q4 2023 and has held it in 12 quarters since.
  • Hanover Advisors's Globus Medical position peaked at $487K in Q4 2025.
  • 615 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Hanover Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.